Chronic Kidney Disease in Patients with Chronic Liver Disease: What Is the Price Tag?

Robert J Wong^{1

2}, Ramsey C Cheung^{1

2}

Affiliations

¹ Division of Gastroenterology and Hepatology Veterans Affairs Palo Alto Health Care System Palo Alto CA.
² Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA.

Editorial

Robert J Wong et al. Hepatol Commun. 2020.

. 2020 Sep 30;4(10):1389-1391.

doi: 10.1002/hep4.1583. eCollection 2020 Oct.

Robert J Wong^{1

2}, Ramsey C Cheung^{1

2}

¹ Division of Gastroenterology and Hepatology Veterans Affairs Palo Alto Health Care System Palo Alto CA.
² Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA.

No abstract available

Figures

1. Hirode G, Saab S, Wong RJ. Trends in the burden of chronic liver disease among hospitalized US adults. JAMA Netw Open 2020;3:e201997. - PMC - PubMed
1. Younossi ZM, Stepanova M, Younossi Y, Golabi P, Mishra A, Rafiq N, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut 2020;69:564‐568. - PubMed
1. Kanwal F, Kramer JR, Duan Z, Yu X, White D, El‐Serag HB. Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans. Clin Gastroenterol Hepatol 2016;14:301‐308.e301‐302. - PMC - PubMed
1. Rustgi VK, Li Y, John T, Catalano C, Elsaid MI. Health care resource use and cost burden of chronic kidney disease in patients with chronic liver disease: a real‐world claims analysis. Hepatol Commun 2020;4:1404‐1418. - PMC - PubMed
1. Targher G, Byrne CD. Non‐alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol 2017;13:297‐310. - PubMed